• Use of imaging methods (Optical Coherence Tomography and magnetic resonance imaging to understand and quantify neurodegenerative processes in neuroimmunological diseases (esp. multiple sclerosis, MS)
• Development of new markers (e.g. retinal ganglion cell layer, thalamic LGN, retinal vessel diameters) for neurodegeneration in the visual pathway and CNS in general and for patient stratification
• Multidisciplinary therapeutic approaches in MS and pain (e.g., musictherapy)
• Migraine, headache
- neuropathic pain